問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2026-02-01

張宇
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2026-07-01 - 2029-05-31

Phase III

Active
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
  • Condition/Disease

    Depressive Disorder, Treatment-Resistant

  • Test Drug

    鼻用噴液劑 鼻用噴液劑

Participate Sites
6Sites

Not yet recruiting4Sites

Recruiting2Sites

2026-01-05 - 2028-09-13

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Recruiting10Sites